Sign in

CIK 0001690585

  • Non-accelerated filer
  • Smaller reporting company

Dianthus Therapeutics, Inc. /DE/

Sign in to watch
Ticker
DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 929-999-4055
Business address
7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
Former names
Magenta Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$16,043,610
in 4 filings, $16.0M under 10b5-1 plans

Net −$16,043,610. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-05-21 Romano Steven J. Director Grant or award · Stock Option (Right to Buy) +6,090 6,090
2025-05-22 Romano Steven J. Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2024-09-16 Romano Steven J. Director Grant or award · Stock Option (Right to Buy) +22,000 22,000

Page 1 of 1 · 3 trades